- Smilow Cancer Hospital at Yale New Haven35 Park StreetNew Haven, CT 06511
Kimberly L. Johung, MD, PhD
Biography
Kimberly L. Johung, MD, PhD, a Yale Medicine radiation oncologist, is the director of the Gastrointestinal Radiotherapy Program for Yale Cancer Center at Smilow Cancer Hospital. She is also the medical director for radiation oncology services at the Veteran Affairs Connecticut Healthcare System in West Haven, Conn.
In these roles, she treats a variety of cancers, including esophageal, gastric, pancreatic, liver, biliary, rectal, anal, and lung tumors. “What inspires me,” says Dr. Johung, “is that my job entails not only helping patients access the best care for their cancer diagnosis, but also trying to provide hope—whether it’s for a cure, a period of disease stability, alleviation of a symptom, or improved outcomes for cancer patients in the future.”
Dr. Johung is also an associate professor of therapeutic radiology at Yale School of Medicine. Her research interests include defining molecular markers, using retrospective studies, clinical trials, and translational studies, to guide treatment decisions and improve outcomes for patients with gastrointestinal malignancies.
She is a panel member for the National Comprehensive Cancer Network (Esophageal and Gastric Cancers) and is a member of the American Society for Radiation Oncology.
Titles
- Associate Professor of Therapeutic Radiology
- Vice Chair for Education, Therapeutic Radiology
- Director of Residency Training Program, Therapeutic Radiology
- Chief, Gastrointestinal Radiotherapy Program, Therapeutic Radiology
- Chief, VA Radiotherapy Program, Therapeutic Radiology
Education & Training
- ResidencyYale-New Haven Hospital (2013)
- InternshipYale-New Haven Hospital (2009)
- MDYale University School of Medicine (2008)
- PhDYale University (2007)
- BAYale University (1999)
Additional Information
- AB of Radiology, Radiation Oncology (2014)
- Chen H, Han D, Draeger E, Zhong W, Lee M, Guan F, Hicks D, Park H, Johung K, Young M, Bal G, Carlson D, Chen Z. Evaluation of Biology-Guided Radiotherapy (BgRT) in Motion Phantom with Real Patient Breathing Patterns. International Journal Of Radiation Oncology • Biology • Physics 2024, 120: e107. DOI: 10.1016/j.ijrobp.2024.07.2018.
- Hicks D, Chen H, Kim J, Tressel L, Wallington D, Becht K, Johung K, Young M, Feghali K, de Jong D, Chen Z, Carlson D, Park H. Impact of Synthetic PET Evaluation prior to PET-Guided Functional Modeling in Optimizing Patient Selection for Biology-Guided Radiotherapy. International Journal Of Radiation Oncology • Biology • Physics 2024, 120: s162-s163. DOI: 10.1016/j.ijrobp.2024.07.2188.
- Benson A, Venook A, Adam M, Chang G, Chen Y, Ciombor K, Cohen S, Cooper H, Deming D, Garrido-Laguna I, Grem J, Haste P, Hecht J, Hoffe S, Hunt S, Hussan H, Johung K, Joseph N, Kirilcuk N, Krishnamurthi S, Malla M, Maratt J, Messersmith W, Meyerhardt J, Miller E, Mulcahy M, Nurkin S, Parikh A, Patel H, Pedersen K, Saltz L, Schneider C, Shibata D, Shogan B, Skibber J, Sofocleous C, Tavakkoli A, Willett C, Wu C, Jones F, Gurski L. NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024. Journal Of The National Comprehensive Cancer Network 2024, 22: 366-375. PMID: 39151454, DOI: 10.6004/jnccn.2024.0041.
- Cecchini M, Salem R, Robert M, Czerniak S, Blaha O, Zelterman D, Rajaei M, Townsend J, Cai G, Chowdhury S, Yugawa D, Tseng R, Arbelaez C, Jiao J, Shroyer K, Thumar J, Kortmansky J, Zaheer W, Fischbach N, Persico J, Stein S, Khan S, Cha C, Billingsley K, Kunstman J, Johung K, Wiess C, Muzumdar M, Spickard E, Aushev V, Laliotis G, Jurdi A, Liu M, Escobar-Hoyos L, Lacy J. Perioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer. JAMA Oncology 2024, 10: 1027-1035. PMID: 38900452, PMCID: PMC11190830, DOI: 10.1001/jamaoncol.2024.1575.
- Verma N, Johung K, Kortmansky J, Zaheer W, Lacy J, Cecchini M, Stein S, Cheng Y, Lam W, Liu S, Reddy V, Hochster H, Higgins S. A single arm phase 2 clinical trial of YIV-906 with neoadjuvant concurrent chemo-radiation therapy in patients with locally advanced rectal cancer. Journal Of Gastrointestinal Oncology 2024, 15: 1050-1059. PMID: 38989411, PMCID: PMC11231844, DOI: 10.21037/jgo-24-23.
- Benson A, Venook A, Adam M, Chang G, Chen Y, Ciombor K, Cohen S, Cooper H, Deming D, Garrido-Laguna I, Grem J, Haste P, Hecht J, Hoffe S, Hunt S, Hussan H, Johung K, Joseph N, Kirilcuk N, Krishnamurthi S, Malla M, Maratt J, Messersmith W, Meyerhardt J, Miller E, Mulcahy M, Nurkin S, Overman M, Parikh A, Patel H, Pedersen K, Saltz L, Schneider C, Shibata D, Shogan B, Skibber J, Sofocleous C, Tavakkoli A, Willett C, Wu C, Gurski L, Snedeker J, Jones F. Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. Journal Of The National Comprehensive Cancer Network 2024, 22 PMID: 38862008, DOI: 10.6004/jnccn.2024.0029.
- Cecchini M, Zhang J, Wei W, Sklar J, Lacy J, Zhong M, Kong Y, Zhao H, DiPalermo J, Devine L, Stein S, Kortmansky J, Johung K, Bindra R, LoRusso P, Schalper K. Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer. Cancer Research Communications 2023, 3: 1132-1139. PMID: 37387791, PMCID: PMC10305782, DOI: 10.1158/2767-9764.crc-23-0045.
- Peters G, Talcott W, Peters N, Dhanasopan A, Lacy J, Cecchini M, Kortmansky J, Stein S, Lattanzi S, Park H, Boffa D, Johung K, Jethwa K. Pre-operative chemoradiotherapy with or without induction chemotherapy for operable locally-advanced esophageal cancer. Journal Of Gastrointestinal Oncology 2023, 14: 1181-1192. PMID: 37435226, PMCID: PMC10331751, DOI: 10.21037/jgo-22-1005.
- Benson A, Venook A, Al-Hawary M, Azad N, Chen Y, Ciombor K, Cohen S, Cooper H, Deming D, Garrido-Laguna I, Grem J, Hecht J, Hoffe S, Hubbard J, Hunt S, Hussan H, Jeck W, Johung K, Joseph N, Kirilcuk N, Krishnamurthi S, Maratt J, Messersmith W, Meyerhardt J, Miller E, Mulcahy M, Nurkin S, Overman M, Parikh A, Patel H, Pedersen K, Saltz L, Schneider C, Shibata D, Skibber J, Sofocleous C, Stotsky-Himelfarb E, Tavakkoli A, Willett C, Williams G, Algieri F, Gurski L, Stehman K. Anal Carcinoma, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. Journal Of The National Comprehensive Cancer Network 2023, 21: 653-677. PMID: 37308125, DOI: 10.6004/jnccn.2023.0030.
- Zhan P, Canavan M, Ermer T, Pichert M, Li A, Maduka R, Kaminski M, Johung K, Boffa D. Utilization and Outcomes of Radiation in Stage IV Esophageal Cancer. JTO Clinical And Research Reports 2022, 3: 100429. PMID: 36483656, PMCID: PMC9722471, DOI: 10.1016/j.jtocrr.2022.100429.
- Oh P, Laird J, Johung K. Impact of Dosimetric Parameters on Local Control after SBRT for Pancreatic Cancer. International Journal Of Radiation Oncology • Biology • Physics 2022, 114: e197. DOI: 10.1016/j.ijrobp.2022.07.1113.
- Laird J, Mokhtech M, Johung K, Park H, Jethwa K. Dosimetric Parameters are Associated with Local Control after SBRT for Colorectal Cancer Lung Metastases. International Journal Of Radiation Oncology • Biology • Physics 2022, 114: e431-e432. DOI: 10.1016/j.ijrobp.2022.07.1640.
- Manjunath R, Rajeev-Kumar G, Tendulkar R, Corbin K, Johung K, Evans S, Shinohara E, Buckstein M, Pinnix C, Harkenrider M, Golden D, Hasan Y. Analyzing Resident Perceptions of Current Radiation Oncology Evaluation Methods. International Journal Of Radiation Oncology • Biology • Physics 2022, 114: e6. DOI: 10.1016/j.ijrobp.2022.06.007.
- Morris L, Viehman J, Baclay J, Chang D, Kerans S, Molitoris J, Regine W, Johung K, Jethwa K, Neibart S, Jabbour S, Hallemeier C. SBRT for the Treatment of Isolated Local Recurrence of Resected Pancreatic Cancer. International Journal Of Radiation Oncology • Biology • Physics 2021, 111: e61. DOI: 10.1016/j.ijrobp.2021.07.408.
- Rajeev-Kumar G, Manjunath R, Harkenrider M, Das P, Tendulkar R, Corbin K, Jagsi R, Marwaha G, Johung K, Evans S, Jawad M, Shinohara E, Komarnicky L, Yeung A, Buckstein M, Golden D, Hasan Y. Preliminary Report Assessing Resident and Faculty Evaluations Across Radiation Oncology Programs. International Journal Of Radiation Oncology • Biology • Physics 2021, 111: e191. DOI: 10.1016/j.ijrobp.2021.07.697.
- Kang X, Qin J, Zhang R, Wang Z, Zheng Q, Li Y, Xu J, Huang J, Wang X, Hui Z, Xue L, Mao Y, Li Y, He J, Chen C, Chen H, Chen K, Chen L, Fu M, Fu J, Geng Q, Gong T, Guo S, Han Y, He Y, Hu J, Jiang H, Jiang J, Jiang Y, Kang M, Ma J, Ma S, Liao Y, Li H, Li S, Li Z, Liu S, Liu Y, Qiao G, Tan L, Tian H, Zhao G, Zhao J, Zheng S, Zhou Y, Nilsson M, Schlottmann F, Rosati R, Stefano C, Chiu P, Newman N, Hirahara N, Kim D, Mehta R, Johung K, Cecchini M, Lloyd S, Meredith K. 2021 NCC/CATS/CSTCVS/STM expert consensus on perioperative immunotherapy for esophageal cancer. Annals Of Esophagus 2021, 4: 33-33. DOI: 10.21037/aoe-21-64.
- Rajeev-Kumar G, Manjunath R, Tendulkar R, Corbin K, Jagsi R, Marwaha G, Johung K, Evans S, Jawad M, Komarnicky-Kocher L, Shinohara E, Yeung A, Buckstein M, Das P, Harkenrider M, Golden D, Hasan Y. Analysis of Resident and Faculty Assessment Methods Used by United States Radiation Oncology Residency Programs. International Journal Of Radiation Oncology • Biology • Physics 2021, 111: e6-e7. DOI: 10.1016/j.ijrobp.2021.05.146.
- Peters G, Jethwa K, Miccio J, Johung K. The Modern Landscape of Gastrointestinal Clinical Trials and Predictors for Success. International Journal Of Radiation Oncology • Biology • Physics 2020, 108: e575. DOI: 10.1016/j.ijrobp.2020.07.1769.
- Miccio J, Mokhtech M, Jabbour S, Anker C, Patel T, Park H, Cecchini M, Salem R, Kuntsman J, Stein S, Kortmansky J, Lacy J, Narang A, Herman J, Haddock M, Hallemeier C, Johung K, Jethwa K. Association of Neoadjuvant Treatment Modality with Negative Margin and Pathologic Downstaging in Patients Undergoing Pancreatic Cancer Resection: A National Cancer Database Analysis. International Journal Of Radiation Oncology • Biology • Physics 2020, 108: e662. DOI: 10.1016/j.ijrobp.2020.07.1980.
- Peters G, Rutter C, Johung K. Anal Cancer. 2020 DOI: 10.1891/9780826155146.0025.
- Peters G, Rutter C, Johung K. Rectal Cancer. 2020 DOI: 10.1891/9780826155146.0024.
- Peters G, Rutter C, Johung K. Pancreatic Cancer. 2020 DOI: 10.1891/9780826155146.0023.
- Peters G, Rutter C, Johung K. Hepatobiliary Cancer. 2020 DOI: 10.1891/9780826155146.0022.
- Peters G, Rutter C, Johung K. Gastric Cancer. 2020 DOI: 10.1891/9780826155146.0021.
- Peters G, Rutter C, Johung K. Esophageal Cancer. 2020 DOI: 10.1891/9780826155146.0020.
- Miccio J, Talcott W, Patel T, Park H, Cecchini M, Salem R, Stein S, Kortmansky J, Lacy J, Johung K, Jethwa K. The Utility of Neoadjuvant Radiotherapy after Neoadjuvant Multiagent Chemotherapy in Patients with Localized Pancreatic Cancer. International Journal Of Radiation Oncology • Biology • Physics 2020, 108: e31-e32. DOI: 10.1016/j.ijrobp.2020.02.538.
- Cecchini M, Miccio JA, Pahade J, Lacy J, Salem RR, Johnson SB, Blakaj A, Stein S, Kortmansky JS, Johung KL. A Single-Institution Experience of Induction 5-Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin Followed by Surgery Versus Consolidative Radiation for Borderline and Locally Advanced Unresectable Pancreatic Cancer. Pancreas 2020, 49: 904-911. PMID: 32658074, DOI: 10.1097/mpa.0000000000001592.
- Miccio JA, Oladeru OT, Jun S, Johung KL. Radiation Therapy for Patients with Advanced Renal Cell Carcinoma. Urologic Clinics Of North America 2020, 47: 399-411. PMID: 32600541, DOI: 10.1016/j.ucl.2020.04.011.
- Miccio J, Ma S, Oladeru O, Yang D, Peters G, Jethwa K, Park H, Hurwitz M, Leapman M, Sprenkle P, Nguyen P, Yu J, Johung K. Association of cytoreductive nephrectomy and survival in the immune checkpoint inhibitor era. Journal Of Clinical Oncology 2020, 38: 748-748. DOI: 10.1200/jco.2020.38.6_suppl.748.
- Miccio J, Johung K. When Surgery Is Not an Option in Renal Cell Carcinoma: The Evolving Role of Stereotactic Body Radiation Therapy. Oncology 2019, 33: 167-73, 177. PMID: 31095714.
- Cecchini M, Miccio J, Pahade J, Lacy J, Salem R, Johnson S, Stein S, Kortmansky J, Johung K. Outcomes for patients with borderline resectable (BR) and locally advanced (LA) pancreatic cancer (PC) treated with induction FOLFIRINOX (FFX) +/- radiation (RT) followed by surgery compared to induction FFX followed by consolidative RT. Journal Of Clinical Oncology 2019, 37: 437-437. DOI: 10.1200/jco.2019.37.4_suppl.437.
- Mancini BR, Stein S, Lloyd S, Rutter CE, James E, Chang BW, Lacy J, Johung KL. Chemoradiation after FOLFIRINOX for borderline resectable or locally advanced pancreatic cancer. Journal Of Gastrointestinal Oncology 2018, 9: 982-988. PMID: 30603116, PMCID: PMC6286925, DOI: 10.21037/jgo.2018.04.03.
- Johung KL, Stein SM. Does Chemoradiation Benefit Patients With Gastric Cancer Managed Without Surgery? Journal Of The National Comprehensive Cancer Network 2018, 16: 1027-1028. PMID: 30099377, DOI: 10.6004/jnccn.2018.7062.
- Johung K, Kann B, Lacy J, Stein S, Kortmansky J, Zaheer W, Cheng Y, Lam W, Liu S, Decker R, Hochster H, Higgins S. P-320 Pilot trial of YIV-906 with neoadjuvant chemoradiotherapy (CRT) in patients with locally advanced rectal cancer. Annals Of Oncology 2018, 29: v90. DOI: 10.1093/annonc/mdy151.319.
- Gao SJ, Park HS, Corso CD, Rutter CE, Khan SA, Johung KL. Post-operative radiotherapy is associated with improved survival in esophageal cancer with positive surgical margins. Journal Of Gastrointestinal Oncology 2017, 8: 953-961. PMID: 29299354, PMCID: PMC5750177, DOI: 10.21037/jgo.2017.08.12.
- Mahal A, Johung K, Mahal B, Nguyen P, Yu J. An Update to Changing Patterns of Anal Carcinoma in the United States. International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e170. DOI: 10.1016/j.ijrobp.2017.06.1008.
- Kann B, Johung K, Cheng Y, Lam W, Liu S, Decker R, Higgins S. Pilot trial of KD018 with neo-adjuvant concurrent chemo-radiation therapy in patients with locally advanced rectal cancer. Journal Of Clinical Oncology 2017, 35: e15162-e15162. DOI: 10.1200/jco.2017.35.15_suppl.e15162.
- Gao SJ, Park HS, Corso CD, Rutter CE, Kim AW, Johung KL. Role of Adjuvant Treatment in Esophageal Cancer With Incidental Pathologic Node Positivity. The Annals Of Thoracic Surgery 2017, 104: 267-274. PMID: 28456393, DOI: 10.1016/j.athoracsur.2017.01.092.
- Kole AJ, Stahl JM, Park HS, Khan SA, Johung KL. Predictors of Nonadherence to NCCN Guideline Recommendations for the Management of Stage I Anal Canal Cancer. Journal Of The National Comprehensive Cancer Network 2017, 15: 355-362. PMID: 28275036, DOI: 10.6004/jnccn.2017.0035.
- Kole A, Stahl J, Park H, Johung K. Predictors of Nonadherence to National Comprehensive Cancer Network Management Guidelines for T1N0 Anal Cancer. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: e211. DOI: 10.1016/j.ijrobp.2016.06.1121.
- Park H, Stahl J, Lester-Coll N, Rutter C, Corso C, Wang E, Husain Z, Decker R, Yu J, Wilson L, Johung K. Impact of Radiation Therapy Facility Case Volume on Survival in Anal Cancer. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: s188. DOI: 10.1016/j.ijrobp.2016.06.469.
- Corso C, Park H, Rutter C, Lester-Coll N, Mancini B, Yeboa D, Johung K. Stereotactic Body Radiation Therapy Versus Conventionally Fractionated Radiation Therapy: A Propensity Score Matched Analysis of Survival in Unresected Pancreatic Cancer. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: s155-s156. DOI: 10.1016/j.ijrobp.2015.07.370.
- Corso C, Wang E, Lester-Coll N, Rutter C, Yeboa D, Mancini B, Yu J, Johung K, Park H. Comparison of Perioperative Chemotherapy and Adjuvant Chemoradiation in Resected Gastric Cancer. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e121. DOI: 10.1016/j.ijrobp.2015.07.855.
- Rutter C, Park H, Corso C, Lester-Coll N, Mancini B, Yeboa D, Johung K. The Addition of Radiation Therapy to Adjuvant Chemotherapy is Associated With Improved Overall Survival in Resected Pancreatic Adenocarcinoma. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: s154-s155. DOI: 10.1016/j.ijrobp.2015.07.368.
- Johung KL, Yeh N, Desai NB, Williams TM, Lautenschlaeger T, Arvold ND, Ning MS, Attia A, Lovly CM, Goldberg S, Beal K, Yu JB, Kavanagh BD, Chiang VL, Camidge DR, Contessa JN. Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non–Small-Cell Lung Cancer and Brain Metastasis. Journal Of Clinical Oncology 2015, 34: 123-129. PMID: 26438117, PMCID: PMC5070549, DOI: 10.1200/jco.2015.62.0138.
- Rutter CE, Park HS, Corso CD, Lester-Coll NH, Mancini BR, Yeboa DN, Johung KL. Addition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: An analysis of the National Cancer Data Base. Cancer 2015, 121: 4141-4149. PMID: 26280559, DOI: 10.1002/cncr.29652.
- Johung KL, Yao X, Li F, Yu JB, Gettinger SN, Goldberg S, Decker RH, Hess JA, Chiang VL, Contessa JN. A Clinical Model for Identifying Radiosensitive Tumor Genotypes in Non–Small Cell Lung Cancer. Clinical Cancer Research 2013, 19: 5523-5532. PMID: 23897899, DOI: 10.1158/1078-0432.ccr-13-0836.
- Johung K, Yu J, Gettinger S, Decker R, Hess J, Chiang V, Contessa J. The Radiosensitivity of Tyrosine Kinase Driven Non-small Cell Lung Cancer. International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s115. DOI: 10.1016/j.ijrobp.2012.07.201.
- Johung K, Rewari A, Wu H, Contessa J, Haffty B, Decker R. Role of Excision Repair Cross Complementation 1 Expression as a Prognostic Marker for Response to Radiotherapy in Early Stage Laryngeal Cancer. International Journal Of Radiation Oncology • Biology • Physics 2010, 78: s663-s664. DOI: 10.1016/j.ijrobp.2010.07.1544.
- Johung K, DiMaio D. Papillomavirus Transformation. 2008, 105-126. DOI: 10.1007/978-0-387-68945-6_5.
- Smilow Cancer Hospital at Yale New Haven35 Park StreetNew Haven, CT 06511
Biography
Kimberly L. Johung, MD, PhD, a Yale Medicine radiation oncologist, is the director of the Gastrointestinal Radiotherapy Program for Yale Cancer Center at Smilow Cancer Hospital. She is also the medical director for radiation oncology services at the Veteran Affairs Connecticut Healthcare System in West Haven, Conn.
In these roles, she treats a variety of cancers, including esophageal, gastric, pancreatic, liver, biliary, rectal, anal, and lung tumors. “What inspires me,” says Dr. Johung, “is that my job entails not only helping patients access the best care for their cancer diagnosis, but also trying to provide hope—whether it’s for a cure, a period of disease stability, alleviation of a symptom, or improved outcomes for cancer patients in the future.”
Dr. Johung is also an associate professor of therapeutic radiology at Yale School of Medicine. Her research interests include defining molecular markers, using retrospective studies, clinical trials, and translational studies, to guide treatment decisions and improve outcomes for patients with gastrointestinal malignancies.
She is a panel member for the National Comprehensive Cancer Network (Esophageal and Gastric Cancers) and is a member of the American Society for Radiation Oncology.
Titles
- Associate Professor of Therapeutic Radiology
- Vice Chair for Education, Therapeutic Radiology
- Director of Residency Training Program, Therapeutic Radiology
- Chief, Gastrointestinal Radiotherapy Program, Therapeutic Radiology
- Chief, VA Radiotherapy Program, Therapeutic Radiology
Education & Training
- ResidencyYale-New Haven Hospital (2013)
- InternshipYale-New Haven Hospital (2009)
- MDYale University School of Medicine (2008)
- PhDYale University (2007)
- BAYale University (1999)
Additional Information
- AB of Radiology, Radiation Oncology (2014)
- Chen H, Han D, Draeger E, Zhong W, Lee M, Guan F, Hicks D, Park H, Johung K, Young M, Bal G, Carlson D, Chen Z. Evaluation of Biology-Guided Radiotherapy (BgRT) in Motion Phantom with Real Patient Breathing Patterns. International Journal Of Radiation Oncology • Biology • Physics 2024, 120: e107. DOI: 10.1016/j.ijrobp.2024.07.2018.
- Hicks D, Chen H, Kim J, Tressel L, Wallington D, Becht K, Johung K, Young M, Feghali K, de Jong D, Chen Z, Carlson D, Park H. Impact of Synthetic PET Evaluation prior to PET-Guided Functional Modeling in Optimizing Patient Selection for Biology-Guided Radiotherapy. International Journal Of Radiation Oncology • Biology • Physics 2024, 120: s162-s163. DOI: 10.1016/j.ijrobp.2024.07.2188.
- Benson A, Venook A, Adam M, Chang G, Chen Y, Ciombor K, Cohen S, Cooper H, Deming D, Garrido-Laguna I, Grem J, Haste P, Hecht J, Hoffe S, Hunt S, Hussan H, Johung K, Joseph N, Kirilcuk N, Krishnamurthi S, Malla M, Maratt J, Messersmith W, Meyerhardt J, Miller E, Mulcahy M, Nurkin S, Parikh A, Patel H, Pedersen K, Saltz L, Schneider C, Shibata D, Shogan B, Skibber J, Sofocleous C, Tavakkoli A, Willett C, Wu C, Jones F, Gurski L. NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024. Journal Of The National Comprehensive Cancer Network 2024, 22: 366-375. PMID: 39151454, DOI: 10.6004/jnccn.2024.0041.
- Cecchini M, Salem R, Robert M, Czerniak S, Blaha O, Zelterman D, Rajaei M, Townsend J, Cai G, Chowdhury S, Yugawa D, Tseng R, Arbelaez C, Jiao J, Shroyer K, Thumar J, Kortmansky J, Zaheer W, Fischbach N, Persico J, Stein S, Khan S, Cha C, Billingsley K, Kunstman J, Johung K, Wiess C, Muzumdar M, Spickard E, Aushev V, Laliotis G, Jurdi A, Liu M, Escobar-Hoyos L, Lacy J. Perioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer. JAMA Oncology 2024, 10: 1027-1035. PMID: 38900452, PMCID: PMC11190830, DOI: 10.1001/jamaoncol.2024.1575.
- Verma N, Johung K, Kortmansky J, Zaheer W, Lacy J, Cecchini M, Stein S, Cheng Y, Lam W, Liu S, Reddy V, Hochster H, Higgins S. A single arm phase 2 clinical trial of YIV-906 with neoadjuvant concurrent chemo-radiation therapy in patients with locally advanced rectal cancer. Journal Of Gastrointestinal Oncology 2024, 15: 1050-1059. PMID: 38989411, PMCID: PMC11231844, DOI: 10.21037/jgo-24-23.
- Benson A, Venook A, Adam M, Chang G, Chen Y, Ciombor K, Cohen S, Cooper H, Deming D, Garrido-Laguna I, Grem J, Haste P, Hecht J, Hoffe S, Hunt S, Hussan H, Johung K, Joseph N, Kirilcuk N, Krishnamurthi S, Malla M, Maratt J, Messersmith W, Meyerhardt J, Miller E, Mulcahy M, Nurkin S, Overman M, Parikh A, Patel H, Pedersen K, Saltz L, Schneider C, Shibata D, Shogan B, Skibber J, Sofocleous C, Tavakkoli A, Willett C, Wu C, Gurski L, Snedeker J, Jones F. Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. Journal Of The National Comprehensive Cancer Network 2024, 22 PMID: 38862008, DOI: 10.6004/jnccn.2024.0029.
- Cecchini M, Zhang J, Wei W, Sklar J, Lacy J, Zhong M, Kong Y, Zhao H, DiPalermo J, Devine L, Stein S, Kortmansky J, Johung K, Bindra R, LoRusso P, Schalper K. Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer. Cancer Research Communications 2023, 3: 1132-1139. PMID: 37387791, PMCID: PMC10305782, DOI: 10.1158/2767-9764.crc-23-0045.
- Peters G, Talcott W, Peters N, Dhanasopan A, Lacy J, Cecchini M, Kortmansky J, Stein S, Lattanzi S, Park H, Boffa D, Johung K, Jethwa K. Pre-operative chemoradiotherapy with or without induction chemotherapy for operable locally-advanced esophageal cancer. Journal Of Gastrointestinal Oncology 2023, 14: 1181-1192. PMID: 37435226, PMCID: PMC10331751, DOI: 10.21037/jgo-22-1005.
- Benson A, Venook A, Al-Hawary M, Azad N, Chen Y, Ciombor K, Cohen S, Cooper H, Deming D, Garrido-Laguna I, Grem J, Hecht J, Hoffe S, Hubbard J, Hunt S, Hussan H, Jeck W, Johung K, Joseph N, Kirilcuk N, Krishnamurthi S, Maratt J, Messersmith W, Meyerhardt J, Miller E, Mulcahy M, Nurkin S, Overman M, Parikh A, Patel H, Pedersen K, Saltz L, Schneider C, Shibata D, Skibber J, Sofocleous C, Stotsky-Himelfarb E, Tavakkoli A, Willett C, Williams G, Algieri F, Gurski L, Stehman K. Anal Carcinoma, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. Journal Of The National Comprehensive Cancer Network 2023, 21: 653-677. PMID: 37308125, DOI: 10.6004/jnccn.2023.0030.
- Zhan P, Canavan M, Ermer T, Pichert M, Li A, Maduka R, Kaminski M, Johung K, Boffa D. Utilization and Outcomes of Radiation in Stage IV Esophageal Cancer. JTO Clinical And Research Reports 2022, 3: 100429. PMID: 36483656, PMCID: PMC9722471, DOI: 10.1016/j.jtocrr.2022.100429.
- Oh P, Laird J, Johung K. Impact of Dosimetric Parameters on Local Control after SBRT for Pancreatic Cancer. International Journal Of Radiation Oncology • Biology • Physics 2022, 114: e197. DOI: 10.1016/j.ijrobp.2022.07.1113.
- Laird J, Mokhtech M, Johung K, Park H, Jethwa K. Dosimetric Parameters are Associated with Local Control after SBRT for Colorectal Cancer Lung Metastases. International Journal Of Radiation Oncology • Biology • Physics 2022, 114: e431-e432. DOI: 10.1016/j.ijrobp.2022.07.1640.
- Manjunath R, Rajeev-Kumar G, Tendulkar R, Corbin K, Johung K, Evans S, Shinohara E, Buckstein M, Pinnix C, Harkenrider M, Golden D, Hasan Y. Analyzing Resident Perceptions of Current Radiation Oncology Evaluation Methods. International Journal Of Radiation Oncology • Biology • Physics 2022, 114: e6. DOI: 10.1016/j.ijrobp.2022.06.007.
- Morris L, Viehman J, Baclay J, Chang D, Kerans S, Molitoris J, Regine W, Johung K, Jethwa K, Neibart S, Jabbour S, Hallemeier C. SBRT for the Treatment of Isolated Local Recurrence of Resected Pancreatic Cancer. International Journal Of Radiation Oncology • Biology • Physics 2021, 111: e61. DOI: 10.1016/j.ijrobp.2021.07.408.
- Rajeev-Kumar G, Manjunath R, Harkenrider M, Das P, Tendulkar R, Corbin K, Jagsi R, Marwaha G, Johung K, Evans S, Jawad M, Shinohara E, Komarnicky L, Yeung A, Buckstein M, Golden D, Hasan Y. Preliminary Report Assessing Resident and Faculty Evaluations Across Radiation Oncology Programs. International Journal Of Radiation Oncology • Biology • Physics 2021, 111: e191. DOI: 10.1016/j.ijrobp.2021.07.697.
- Kang X, Qin J, Zhang R, Wang Z, Zheng Q, Li Y, Xu J, Huang J, Wang X, Hui Z, Xue L, Mao Y, Li Y, He J, Chen C, Chen H, Chen K, Chen L, Fu M, Fu J, Geng Q, Gong T, Guo S, Han Y, He Y, Hu J, Jiang H, Jiang J, Jiang Y, Kang M, Ma J, Ma S, Liao Y, Li H, Li S, Li Z, Liu S, Liu Y, Qiao G, Tan L, Tian H, Zhao G, Zhao J, Zheng S, Zhou Y, Nilsson M, Schlottmann F, Rosati R, Stefano C, Chiu P, Newman N, Hirahara N, Kim D, Mehta R, Johung K, Cecchini M, Lloyd S, Meredith K. 2021 NCC/CATS/CSTCVS/STM expert consensus on perioperative immunotherapy for esophageal cancer. Annals Of Esophagus 2021, 4: 33-33. DOI: 10.21037/aoe-21-64.
- Rajeev-Kumar G, Manjunath R, Tendulkar R, Corbin K, Jagsi R, Marwaha G, Johung K, Evans S, Jawad M, Komarnicky-Kocher L, Shinohara E, Yeung A, Buckstein M, Das P, Harkenrider M, Golden D, Hasan Y. Analysis of Resident and Faculty Assessment Methods Used by United States Radiation Oncology Residency Programs. International Journal Of Radiation Oncology • Biology • Physics 2021, 111: e6-e7. DOI: 10.1016/j.ijrobp.2021.05.146.
- Peters G, Jethwa K, Miccio J, Johung K. The Modern Landscape of Gastrointestinal Clinical Trials and Predictors for Success. International Journal Of Radiation Oncology • Biology • Physics 2020, 108: e575. DOI: 10.1016/j.ijrobp.2020.07.1769.
- Miccio J, Mokhtech M, Jabbour S, Anker C, Patel T, Park H, Cecchini M, Salem R, Kuntsman J, Stein S, Kortmansky J, Lacy J, Narang A, Herman J, Haddock M, Hallemeier C, Johung K, Jethwa K. Association of Neoadjuvant Treatment Modality with Negative Margin and Pathologic Downstaging in Patients Undergoing Pancreatic Cancer Resection: A National Cancer Database Analysis. International Journal Of Radiation Oncology • Biology • Physics 2020, 108: e662. DOI: 10.1016/j.ijrobp.2020.07.1980.
- Peters G, Rutter C, Johung K. Anal Cancer. 2020 DOI: 10.1891/9780826155146.0025.
- Peters G, Rutter C, Johung K. Rectal Cancer. 2020 DOI: 10.1891/9780826155146.0024.
- Peters G, Rutter C, Johung K. Pancreatic Cancer. 2020 DOI: 10.1891/9780826155146.0023.
- Peters G, Rutter C, Johung K. Hepatobiliary Cancer. 2020 DOI: 10.1891/9780826155146.0022.
- Peters G, Rutter C, Johung K. Gastric Cancer. 2020 DOI: 10.1891/9780826155146.0021.
- Peters G, Rutter C, Johung K. Esophageal Cancer. 2020 DOI: 10.1891/9780826155146.0020.
- Miccio J, Talcott W, Patel T, Park H, Cecchini M, Salem R, Stein S, Kortmansky J, Lacy J, Johung K, Jethwa K. The Utility of Neoadjuvant Radiotherapy after Neoadjuvant Multiagent Chemotherapy in Patients with Localized Pancreatic Cancer. International Journal Of Radiation Oncology • Biology • Physics 2020, 108: e31-e32. DOI: 10.1016/j.ijrobp.2020.02.538.
- Cecchini M, Miccio JA, Pahade J, Lacy J, Salem RR, Johnson SB, Blakaj A, Stein S, Kortmansky JS, Johung KL. A Single-Institution Experience of Induction 5-Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin Followed by Surgery Versus Consolidative Radiation for Borderline and Locally Advanced Unresectable Pancreatic Cancer. Pancreas 2020, 49: 904-911. PMID: 32658074, DOI: 10.1097/mpa.0000000000001592.
- Miccio JA, Oladeru OT, Jun S, Johung KL. Radiation Therapy for Patients with Advanced Renal Cell Carcinoma. Urologic Clinics Of North America 2020, 47: 399-411. PMID: 32600541, DOI: 10.1016/j.ucl.2020.04.011.
- Miccio J, Ma S, Oladeru O, Yang D, Peters G, Jethwa K, Park H, Hurwitz M, Leapman M, Sprenkle P, Nguyen P, Yu J, Johung K. Association of cytoreductive nephrectomy and survival in the immune checkpoint inhibitor era. Journal Of Clinical Oncology 2020, 38: 748-748. DOI: 10.1200/jco.2020.38.6_suppl.748.
- Miccio J, Johung K. When Surgery Is Not an Option in Renal Cell Carcinoma: The Evolving Role of Stereotactic Body Radiation Therapy. Oncology 2019, 33: 167-73, 177. PMID: 31095714.
- Cecchini M, Miccio J, Pahade J, Lacy J, Salem R, Johnson S, Stein S, Kortmansky J, Johung K. Outcomes for patients with borderline resectable (BR) and locally advanced (LA) pancreatic cancer (PC) treated with induction FOLFIRINOX (FFX) +/- radiation (RT) followed by surgery compared to induction FFX followed by consolidative RT. Journal Of Clinical Oncology 2019, 37: 437-437. DOI: 10.1200/jco.2019.37.4_suppl.437.
- Mancini BR, Stein S, Lloyd S, Rutter CE, James E, Chang BW, Lacy J, Johung KL. Chemoradiation after FOLFIRINOX for borderline resectable or locally advanced pancreatic cancer. Journal Of Gastrointestinal Oncology 2018, 9: 982-988. PMID: 30603116, PMCID: PMC6286925, DOI: 10.21037/jgo.2018.04.03.
- Johung KL, Stein SM. Does Chemoradiation Benefit Patients With Gastric Cancer Managed Without Surgery? Journal Of The National Comprehensive Cancer Network 2018, 16: 1027-1028. PMID: 30099377, DOI: 10.6004/jnccn.2018.7062.
- Johung K, Kann B, Lacy J, Stein S, Kortmansky J, Zaheer W, Cheng Y, Lam W, Liu S, Decker R, Hochster H, Higgins S. P-320 Pilot trial of YIV-906 with neoadjuvant chemoradiotherapy (CRT) in patients with locally advanced rectal cancer. Annals Of Oncology 2018, 29: v90. DOI: 10.1093/annonc/mdy151.319.
- Gao SJ, Park HS, Corso CD, Rutter CE, Khan SA, Johung KL. Post-operative radiotherapy is associated with improved survival in esophageal cancer with positive surgical margins. Journal Of Gastrointestinal Oncology 2017, 8: 953-961. PMID: 29299354, PMCID: PMC5750177, DOI: 10.21037/jgo.2017.08.12.
- Mahal A, Johung K, Mahal B, Nguyen P, Yu J. An Update to Changing Patterns of Anal Carcinoma in the United States. International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e170. DOI: 10.1016/j.ijrobp.2017.06.1008.
- Kann B, Johung K, Cheng Y, Lam W, Liu S, Decker R, Higgins S. Pilot trial of KD018 with neo-adjuvant concurrent chemo-radiation therapy in patients with locally advanced rectal cancer. Journal Of Clinical Oncology 2017, 35: e15162-e15162. DOI: 10.1200/jco.2017.35.15_suppl.e15162.
- Gao SJ, Park HS, Corso CD, Rutter CE, Kim AW, Johung KL. Role of Adjuvant Treatment in Esophageal Cancer With Incidental Pathologic Node Positivity. The Annals Of Thoracic Surgery 2017, 104: 267-274. PMID: 28456393, DOI: 10.1016/j.athoracsur.2017.01.092.
- Kole AJ, Stahl JM, Park HS, Khan SA, Johung KL. Predictors of Nonadherence to NCCN Guideline Recommendations for the Management of Stage I Anal Canal Cancer. Journal Of The National Comprehensive Cancer Network 2017, 15: 355-362. PMID: 28275036, DOI: 10.6004/jnccn.2017.0035.
- Kole A, Stahl J, Park H, Johung K. Predictors of Nonadherence to National Comprehensive Cancer Network Management Guidelines for T1N0 Anal Cancer. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: e211. DOI: 10.1016/j.ijrobp.2016.06.1121.
- Park H, Stahl J, Lester-Coll N, Rutter C, Corso C, Wang E, Husain Z, Decker R, Yu J, Wilson L, Johung K. Impact of Radiation Therapy Facility Case Volume on Survival in Anal Cancer. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: s188. DOI: 10.1016/j.ijrobp.2016.06.469.
- Corso C, Park H, Rutter C, Lester-Coll N, Mancini B, Yeboa D, Johung K. Stereotactic Body Radiation Therapy Versus Conventionally Fractionated Radiation Therapy: A Propensity Score Matched Analysis of Survival in Unresected Pancreatic Cancer. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: s155-s156. DOI: 10.1016/j.ijrobp.2015.07.370.
- Corso C, Wang E, Lester-Coll N, Rutter C, Yeboa D, Mancini B, Yu J, Johung K, Park H. Comparison of Perioperative Chemotherapy and Adjuvant Chemoradiation in Resected Gastric Cancer. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e121. DOI: 10.1016/j.ijrobp.2015.07.855.
- Rutter C, Park H, Corso C, Lester-Coll N, Mancini B, Yeboa D, Johung K. The Addition of Radiation Therapy to Adjuvant Chemotherapy is Associated With Improved Overall Survival in Resected Pancreatic Adenocarcinoma. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: s154-s155. DOI: 10.1016/j.ijrobp.2015.07.368.
- Johung KL, Yeh N, Desai NB, Williams TM, Lautenschlaeger T, Arvold ND, Ning MS, Attia A, Lovly CM, Goldberg S, Beal K, Yu JB, Kavanagh BD, Chiang VL, Camidge DR, Contessa JN. Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non–Small-Cell Lung Cancer and Brain Metastasis. Journal Of Clinical Oncology 2015, 34: 123-129. PMID: 26438117, PMCID: PMC5070549, DOI: 10.1200/jco.2015.62.0138.
- Rutter CE, Park HS, Corso CD, Lester-Coll NH, Mancini BR, Yeboa DN, Johung KL. Addition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: An analysis of the National Cancer Data Base. Cancer 2015, 121: 4141-4149. PMID: 26280559, DOI: 10.1002/cncr.29652.
- Johung KL, Yao X, Li F, Yu JB, Gettinger SN, Goldberg S, Decker RH, Hess JA, Chiang VL, Contessa JN. A Clinical Model for Identifying Radiosensitive Tumor Genotypes in Non–Small Cell Lung Cancer. Clinical Cancer Research 2013, 19: 5523-5532. PMID: 23897899, DOI: 10.1158/1078-0432.ccr-13-0836.
- Johung K, Yu J, Gettinger S, Decker R, Hess J, Chiang V, Contessa J. The Radiosensitivity of Tyrosine Kinase Driven Non-small Cell Lung Cancer. International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s115. DOI: 10.1016/j.ijrobp.2012.07.201.
- Johung K, Rewari A, Wu H, Contessa J, Haffty B, Decker R. Role of Excision Repair Cross Complementation 1 Expression as a Prognostic Marker for Response to Radiotherapy in Early Stage Laryngeal Cancer. International Journal Of Radiation Oncology • Biology • Physics 2010, 78: s663-s664. DOI: 10.1016/j.ijrobp.2010.07.1544.
- Johung K, DiMaio D. Papillomavirus Transformation. 2008, 105-126. DOI: 10.1007/978-0-387-68945-6_5.
- Smilow Cancer Hospital at Yale New Haven35 Park StreetNew Haven, CT 06511
- Smilow Cancer Hospital at Yale New Haven35 Park StreetNew Haven, CT 06511